Fibrocell Science, Inc.·4

Jan 29, 1:08 PM ET

Maslowski John Michael 4

4 · Fibrocell Science, Inc. · Filed Jan 29, 2018

Insider Transaction Report

Form 4
Period: 2018-01-25
Maslowski John Michael
VP, Scientific Affairs
Transactions
  • Award

    Option to Purchase Common Stock

    2018-01-25+100,000100,000 total
    Exercise: $0.69Exp: 2028-01-25Common Stock (100,000 underlying)
Footnotes (2)
  • [F1]The options set forth in this table vest as follows: (i) 25,000 shares on January 25, 2019 and (ii) 6,250 shares for each of twelve quarterly installments beginning on April 25, 2019 and ending on January 25, 2022 provided the reporting person is employed by the Company on each vesting date.
  • [F2]The options were issued in connection with the reporting person's employment service to the Company.

Documents

1 file
  • 4
    wf-form4_151724929635506.xmlPrimary

    FORM 4